Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,761 to 1,780 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TAZ functions as a tumor suppressor in multiple myeloma by downregulating MYC. | Blood Adv | 2019 | 31743393 | PubTator, text mining | PubMed |
| Multi-omics analysis reveals epithelial-mesenchymal transition-related gene FOXM1 as a novel prognostic biomarker in clear cell renal carcinoma. | Aging (Albany NY) | 2019 | 31743108 | PubTator, text mining | PubMed |
| Essential Oil from Pinus Koraiensis Pinecones Inhibits Gastric Cancer Cells via the HIPPO/YAP Signaling Pathway. | Molecules | 2019 | 31731517 | PubTator, text mining | PubMed |
| Atheroprotective effects of methotrexate via the inhibition of YAP/TAZ under disturbed flow. | J Transl Med | 2019 | 31730006 | PubTator, text mining | PubMed |
| TNFAIP8: Inflammation, Immunity and Human Diseases. | J Cell Immunol | 2019 | 31723944 | PubTator, text mining | PubMed |
| Loss of Mob1a/b impairs the differentiation of mouse embryonic stem cells into the three germ layer lineages. | Exp Mol Med | 2019 | 31723125 | PubTator, text mining | PubMed |
| Mechanisms and Functions of Long Non-Coding RNAs at Multiple Regulatory Levels. | Int J Mol Sci | 2019 | 31717266 | PubTator, text mining | PubMed |
| Tanshinone IIA mediates SMAD7-YAP interaction to inhibit liver cancer growth by inactivating the transforming growth factor beta signaling pathway. | Aging (Albany NY) | 2019 | 31711043 | PubTator, text mining | PubMed |
| Curcumin derivative WZ35 inhibits tumor cell growth via ROS-YAP-JNK signaling pathway in breast cancer. | J Exp Clin Cancer Res | 2019 | 31703744 | PubTator, text mining | PubMed |
| Prevention of calpain-dependent degradation of STK38 by MEKK2-mediated phosphorylation. | Sci Rep | 2019 | 31690749 | PubTator, text mining | PubMed |
| Neural precursor cell-expressed, developmentally down-regulated 4 (NEDD4) regulates hydrogen peroxide-induced cell proliferation and death through inhibition of Hippo signaling. | FASEB J | 2019 | 31690112 | PubTator, text mining | PubMed |
| hsa_circ_0092306 Targeting miR-197-3p Promotes Gastric Cancer Development by Regulating PRKCB in MKN-45 Cells. | Mol Ther Nucleic Acids | 2019 | 31689616 | PubTator, text mining | PubMed |
| Mask family proteins ANKHD1 and ANKRD17 regulate YAP nuclear import and stability. | Elife | 2019 | 31661072 | PubTator, text mining | PubMed |
| PR55α regulatory subunit of PP2A inhibits the MOB1/LATS cascade and activates YAP in pancreatic cancer cells. | Oncogenesis | 2019 | 31659153 | PubTator, text mining | PubMed |
| Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancer. | EMBO Mol Med | 2019 | 31633304 | PubTator, text mining | PubMed |
| A Feedback Loop Regulation Of LINC01433 And YAP Promotes Malignant Behavior In Gastric Cancer Cells. | Onco Targets Ther | 2019 | 31632054 | PubTator, text mining | PubMed |
| YAP Inhibition by Nuciferine via AMPK-Mediated Downregulation of HMGCR Sensitizes Pancreatic Cancer Cells to Gemcitabine. | Biomolecules | 2019 | 31627466 | PubTator, text mining | PubMed |
| Overexpression of lncRNA PIK3CD-AS1 promotes expression of LATS1 by competitive binding with microRNA-566 to inhibit the growth, invasion and metastasis of hepatocellular carcinoma cells. | Cancer Cell Int | 2019 | 31624469 | PubTator, text mining | PubMed |
| MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma. | J Exp Clin Cancer Res | 2019 | 31623651 | PubTator, text mining | PubMed |
| Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3. | Mol Cancer | 2019 | 31619268 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=89